Skip to content

Comparative study between parallel groups with placebo for women with daily fatigue

Comparative study between parallel groups with placebo for women with daily fatigue - Study for women with daily fatigue

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038878
Enrollment
60
Registered
2019-12-13
Start date
2020-01-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Intake 2 tablets of Test food A* daily for 4 weeks. *Test food A and B are capsules containing either placebo (dextrin 400mg) or maca extract 400mg. Intake 2 tablets of Test food B* daily for 4 wee

Sponsors

Healthcare Systems Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2.Healthy Japanese who are 20 years old or more and under 65 years old 3.Persons who with chronic (daily) fatigue 4.Persons who are the top 60 of the value of Fatigue VAS at the screening

Exclusion criteria

Exclusion criteria: 1.Persons who have chronic illness, receiving medication, have a serious disease history 2.Persons who are allergic to the test food 3.Persons who regularly use medicines, specified insurance foods, health foods, etc. that may affect physical and mental fatigue 4.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 5.Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding 6.Persons who were judged as inappropriate for subjects by the principal investigator

Design outcomes

Primary

MeasureTime frame
Fatigue VAS at the beginning of the test or after ingestion of four weeks.

Countries

Japan

Contacts

Public ContactAkiko Okamura

Healthcare Systems Co., Ltd. Research and Development Department

okamura@hc-sys.jp03-6809-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026